Meridiem Capital Partners LP Bio Techne Corp Transaction History
Meridiem Capital Partners LP
- $1.56 Trillion
- Q3 2025
A detailed history of Meridiem Capital Partners LP transactions in Bio Techne Corp stock. As of the latest transaction made, Meridiem Capital Partners LP holds 210,947 shares of TECH stock, worth $12.5 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
210,947Holding current value
$12.5 Million% of portfolio
0.75%Shares
2 transactions
Others Institutions Holding TECH
# of Institutions
648Shares Held
162MCall Options Held
514KPut Options Held
347K-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.06 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$890 Million0.02% of portfolio
-
Morgan Stanley New York, NY7.24MShares$430 Million0.03% of portfolio
-
State Street Corp Boston, MA5.75MShares$342 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA5.12MShares$304 Million0.05% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.33B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...